Ministry of Health Immunisation Update

Date: 
Friday, June 4, 2021

Influenza vaccines

In this emailed Ministry of Health Immunisation Update, the Ministry highlighted the importance of administering the correct influenza vaccine for each age group to ensure that everyone who would like an influenza vaccination has access to one.

AGE VACCINE TO BE USED
6–35 months of age Afluria Quad Junior
3 & 4 years of age Influvac Tetra
5 years of age and older,
including adults aged 65 years or older
Afluria Quad
65 years or older Fluad Quad

The start of the Influenza Immunisation Programme for those aged 65 years or older has been very successflu. Stock of Fluad Quad is low. Afluria Quad can also be used and is funded for those aged 65 years or older.

The Ministry requests vaccinators focus on providing influenza vacicnation to children and adults with underlying health conditions, and adults aged 65 years or older, as the groups have an increased risk of developing complications from influenza.

Administering the influenza and COVID-19 vaccines

The Ministry has requested that providers please remind people of the importance of both the COVID-19 and influenza vaccines. Some in the community may be unaware that the COVID-19 vaccine does not provide immunity for both COVID-19 and influenza.  

  • If a person has an appointment booked for the COVID-19 vaccine, they should get that first.
  • If they don’t have an appointment for the COVID-19 vaccine yet, they should get the flu vaccine first. There’s more information about this on the Ministry of Health Influenza webpage.
  • Where possible, there should be a gap of two weeks or more between the influenza and COVID-19 vaccinations. However, there are no clinical safety concerns should the gap between vaccines be less than two weeks. 

The Immunisation Update also provides information on:

  • Protecting health workers from flu – funding and reimbursements

  • National Immunisations Register entries by pharmacies

  • Treasure our Whānau – influenza communications resources

  • Evaluation of the Māori Influenza Vaccination Programme 2020